Aram Hezel, MD, Oncology, Rochester, NY, Highland Hospital

AramFrancisHezelMD

Oncology Rochester, NY

Gastrointestinal Cancer, Hematologic Oncology

Associate Professor, Medicine, University of Rochester School of Medicine & Dentistry

Dr. Hezel is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hezel's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Hematology/Oncology, 2003 - 2006
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2003
  • University at Buffalo, School of Medicine and Biomedical Sciences
    University at Buffalo, School of Medicine and Biomedical SciencesClass of 2000

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2009 - 2022
  • MA State Medical License
    MA State Medical License 2002 - 2010
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic Cancer  
    Richard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature

Press Mentions

  • Study Points to Obesity as Driver of Pancreatic Cancer
    Study Points to Obesity as Driver of Pancreatic CancerApril 16th, 2020
  • The Most Groundbreaking Cancer Research of 2017
    The Most Groundbreaking Cancer Research of 2017December 9th, 2017

Grant Support

  • Genomic Instability And The Roles Of P53 And P19ARF In Pancreatic CancerNational Cancer Institute2009–2010
  • Genomic Instability And The Roles Of P53 And P19ARF In Pancreatic CancerNational Cancer Institute2006–2008

Hospital Affiliations